The hyperthermic effect of central cholecystokinin is mediated by the cyclooxygenase-2 pathway
- 1 January 2022
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 322 (1) , E10-E23
Abstract
Cholecystokinin (CCK) increases core body temperature via CCK2 receptors when administered intracerebroventricularly (icv). The mechanisms of CCK-induced hyperthermia are unknown, and it is also unknown whether CCK contributes to the fever response to systemic inflammation. We studied the interaction between central CCK signaling and the cyclooxygenase (COX) pathway. Body temperature was measured in adult male Wistar rats pretreated with intraperitoneal infusion of the nonselective COX enzyme inhibitor metamizol (120 mg/kg) or a selective COX-2 inhibitor, meloxicam, or etoricoxib (10 mg/kg for both) and, 30 min later, treated with intracerebroventricular CCK (1.7 µg/kg). In separate experiments, CCK-induced neuronal activation (with and without COX inhibition) was studied in thermoregulation- and feeding-related nuclei with c-Fos immunohistochemistry. CCK increased body temperature by ∼0.4°C from 10 min postinfusion, which was attenuated by metamizol. CCK reduced the number of c-Fos-positive cells in the median preoptic area (by ∼70%) but increased it in the dorsal hypothalamic area and in the rostral raphe pallidus (by ∼50% in both); all these changes were completely blocked with metamizol. In contrast, CCK-induced satiety and neuronal activation in the ventromedial hypothalamus were not influenced by metamizol. CCK-induced hyperthermia was also completely blocked with both selective COX-2 inhibitors studied. Finally, the CCK2 receptor antagonist YM022 (10 µg/kg icv) attenuated the late phases of fever induced by bacterial lipopolysaccharide (10 µg/kg; intravenously). We conclude that centrally administered CCK causes hyperthermia through changes in the activity of “classical” thermoeffector pathways and that the activation of COX-2 is required for the development of this response. NEW & NOTEWORTHY An association between central cholecystokinin signaling and the cyclooxygenase-prostaglandin E pathway has been proposed but remained poorly understood. We show that the hyperthermic response to the central administration of cholecystokinin alters the neuronal activity within efferent thermoeffector pathways and that these effects are fully blocked by the inhibition of cyclooxygenase. We also show that the activation of cyclooxygenase-2 is required for the hyperthermic effect of cholecystokinin and that cholecystokinin is a modulator of endotoxin-induced fever.Keywords
Funding Information
- Ministry for Innovation and Technology, Hungary (UNKP-20-4-II-PTE-547)
- Ministry for Innovation and Technology, Hungary (UNKP-21-3-II-PTE-1317)
- Emberi Eroforrások Minisztériuma (3/2018/FEKUTSTRAT)
- European Union (EU) | European Social Fund (EFOP-3.6.1-16-2016-00004)
- Nemzeti Kutatási és Technológiai Hivatal (TKP2020-IKA-08)
- Magyar Tudományos Akadémia (MTA-TKI14016)
- European Union (EU) | European Social Fund (EFOP-3.6.3-VEKOP- 16-2017-00009)
- European Union (EU) | European Social Fund (EFOP-3.6.1.-16-2016-00004)
- European Union (EU) | European Social Fund (EFOP-3.6.2-16-2017-00008)
- European Regional Developmental Fund (GINOP-2.3.2-15-2016-00050)
- Magyar Tudományos Akadémia (NAP 2017-1.2.1-NKP-2017-00002)
- Nemzeti Kutatási és Technológiai Hivatal (FK 138722)
- University of Pecs (KA-2019-27)
- Magyar Tudományos Akadémia (Janos Bolyai Scholarship)
This publication has 117 references indexed in Scilit:
- Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E2 in the spinal cordPain, 2012
- Novel bioactive metabolites of dipyrone (metamizol)Bioorganic & Medicinal Chemistry, 2012
- Cholecystokinin Knockout Mice Are Resistant to High-Fat Diet-Induced ObesityGastroenterology, 2010
- Cyclooxygenase-1 or -2—which one mediates lipopolysaccharide-induced hypothermia?American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitroToxicology and Applied Pharmacology, 2009
- Central pathway for spontaneous and prostaglandin E2-evoked cutaneous vasoconstrictionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Preoptic mechanism for cold‐defensive responses to skin coolingThe Journal of Physiology, 2008
- Central efferent pathways mediating skin cooling-evoked sympathetic thermogenesis in brown adipose tissueAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Cellular and Molecular Bases of the Initiation of FeverPLOS Biology, 2006
- Gastrin promotes human colon cancer cell growth via CCK‐2 receptor‐mediated cyclooxygenase‐2 induction and prostaglandin E2 productionBritish Journal of Pharmacology, 2005